Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
J Radiol Prot ; 44(2)2024 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-38834050

RESUMEN

Interventional radiology is a clinical practice with important benefits for patients, but which involves high radiation doses. The optimisation of radiation protection (RP) for paediatric interventional cardiology is a priority for both patients and staff. The use of diagnostic reference levels (DRLs) has been proposed by the International Commission on Radiological Protection to improve RP in imaging procedures. Dose management systems (DMSs) allow the automatic collection of dosimetric, geometric and technical data to assist the optimisation process, with a continuous audit of the procedures, generating alerts to implement corrective actions when necessary. Patient dose indicators may be analysed individually and for different radiation events (fluoroscopy and cine runs). Occupational doses per procedure may be analysed (if electronic dosimeters are available) and linked with patient doses for an integrated approach to RP. Regional optimisation programmes require data collection and processing from several countries to set and periodically update the DRLs. Patient data is anonymised, and each participating hospital has access to their data in a central computer server. Using DMSs may be one of the best ways to support these programs in the collection and analysis of data, raising alerts about high patient and occupational doses and suggesting optimisation actions.


Asunto(s)
Exposición Profesional , Dosis de Radiación , Protección Radiológica , Protección Radiológica/normas , Humanos , Exposición Profesional/prevención & control , Exposición Profesional/análisis , Radiografía Intervencional , Monitoreo de Radiación/métodos , Niveles de Referencia para Diagnóstico , Radiología Intervencionista
2.
Actas Dermosifiliogr ; 114(5): 371-376, 2023 May.
Artículo en Inglés, Español | MEDLINE | ID: mdl-36740178

RESUMEN

INTRODUCTION: Since 2021, an increase in cases of tinea capitis has been detected in adolescents who shave their hair with fade haircut. PATIENTS AND METHODS: Multicenter retrospective observational study of cases of cephalic pole dermatophytosis with a history of having been acquired after frequent shaving in hairdressing. A call was made to dermatologists from the Spanish Academy of Dermatology and Venereology (AEDV) to provide cases observed between January 2021 and December 2022. Patients with microbiological confirmation by culture or direct examination with KOH were included. RESULTS: 107 cases were collected, 106 of which were male. 78 non-inflammatory forms were observed, compared to 29 inflammatory. The most frequently isolated fungus was Trichophyton tonsurans (75.7% of cases). The lesions appeared predominantly on the nape of the neck and temporal area. CONCLUSIONS: The distribution by sex, age and lesional location seems to indicate that a new social trend, in which male adolescents regularly go to hairdressers to shave the occipital and temporal areas, would be the cause of this grouping of cases of ringworm of the scalp. The most frequent microorganism in our study (T.tonsurans) coincides with the most prevalent in our environment. This study shows an accumulation of cases that can be taken into account by competent Public Health agencies, which are responsible for ensuring compliance with the rules of disinfection of the material used for shaving.


Asunto(s)
Arthrodermataceae , Tiña del Cuero Cabelludo , Adolescente , Humanos , Masculino , Femenino , Trichophyton , Tiña del Cuero Cabelludo/epidemiología , Tiña del Cuero Cabelludo/microbiología , Cuero Cabelludo , Brotes de Enfermedades
3.
Mol Psychiatry ; 21(5): 608-14, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26239289

RESUMEN

Opioid dependence, a severe addictive disorder and major societal problem, has been demonstrated to be moderately heritable. We conducted a genome-wide association study in Comorbidity and Trauma Study data comparing opioid-dependent daily injectors (N=1167) with opioid misusers who never progressed to daily injection (N=161). The strongest associations, observed for CNIH3 single-nucleotide polymorphisms (SNPs), were confirmed in two independent samples, the Yale-Penn genetic studies of opioid, cocaine and alcohol dependence and the Study of Addiction: Genetics and Environment, which both contain non-dependent opioid misusers and opioid-dependent individuals. Meta-analyses found five genome-wide significant CNIH3 SNPs. The A allele of rs10799590, the most highly associated SNP, was robustly protective (P=4.30E-9; odds ratio 0.64 (95% confidence interval 0.55-0.74)). Epigenetic annotation predicts that this SNP is functional in fetal brain. Neuroimaging data from the Duke Neurogenetics Study (N=312) provide evidence of this SNP's in vivo functionality; rs10799590 A allele carriers displayed significantly greater right amygdala habituation to threat-related facial expressions, a phenotype associated with resilience to psychopathology. Computational genetic analyses of physical dependence on morphine across 23 mouse strains yielded significant correlations for haplotypes in CNIH3 and functionally related genes. These convergent findings support CNIH3 involvement in the pathophysiology of opioid dependence, complementing prior studies implicating the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate system.


Asunto(s)
Predisposición Genética a la Enfermedad , Trastornos Relacionados con Opioides/genética , Polimorfismo de Nucleótido Simple , Receptores AMPA/genética , Amígdala del Cerebelo/diagnóstico por imagen , Amígdala del Cerebelo/fisiopatología , Animales , Femenino , Estudio de Asociación del Genoma Completo , Habituación Psicofisiológica/genética , Habituación Psicofisiológica/fisiología , Humanos , Masculino , Ratones Endogámicos , Trastornos Relacionados con Opioides/diagnóstico por imagen , Trastornos Relacionados con Opioides/fisiopatología , Receptores AMPA/metabolismo , Especificidad de la Especie , Adulto Joven
4.
Eur J Neurosci ; 41(7): 901--7, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25639561

RESUMEN

Opioids are well known for their robust analgesic effects. Chronic activation of mu opioid receptors (MOPs) is, however, accompanied by various unwanted effects such as analgesic tolerance. Among other mechanisms, interactions between MOPs and delta opioid receptors (DOPs) are thought to play an important role in morphine-induced behavioral adaptations. Interestingly, certain conditions such as inflammation enhance the function of the DOP through a MOP-dependent mechanism. Here, we investigated the role of DOPs during the development of morphine tolerance in an animal model of chronic inflammatory pain. Using behavioral approaches, we first established that repeated systemic morphine treatment induced morphine analgesic tolerance in rats coping with chronic inflammatory pain. We then observed that blockade of DOPs with subcutaneous naltrindole (NTI), a selective DOP antagonist, significantly attenuated the development of morphine tolerance in a dose-dependent manner. We confirmed that this effect was DOP mediated by showing that an acute injection of NTI had no effect on morphine-induced analgesia in naive animals. Previous pharmacological characterizations revealed the existence of DOP subtype 1 and DOP subtype 2. As opposed to NTI, 7-benzylidenenaltrexone and naltriben were reported to be selective DOP subtype 1 and DOP subtype 2 antagonists, respectively. Interestingly, naltriben but not 7-benzylidenenaltrexone was able to attenuate the development of morphine analgesic tolerance in inflamed rats. Altogether, our results suggest that targeting of DOP subtype 2 with antagonists provides a valuable strategy to attenuate the analgesic tolerance that develops after repeated morphine administration in the setting of chronic inflammatory pain.


Asunto(s)
Analgésicos Opioides/farmacología , Dolor Crónico/tratamiento farmacológico , Tolerancia a Medicamentos/fisiología , Inflamación/fisiopatología , Morfina/farmacología , Receptores Opioides delta/metabolismo , Animales , Compuestos de Bencilideno/farmacología , Dolor Crónico/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Adyuvante de Freund , Miembro Posterior , Masculino , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Ratas Sprague-Dawley , Receptores Opioides delta/antagonistas & inhibidores
5.
Radiologia ; 55 Suppl 2: 35-40, 2013 Dec.
Artículo en Español | MEDLINE | ID: mdl-24246884

RESUMEN

There is a consensus in the international community regarding both the need for and benefits of systematic registration and planning of the dosage indicators in patients exposed to ionizing radiation. The main interest is in the registration and follow-up of the techniques and procedures that can involve the greatest risk from exposure to radiation. This register should be planned to include the structure and tools necessary to take the radiological safety of the patients into account, enabling the physicians requesting the studies to access the most important information in the register so they can appropriately justify the request for additional studies. Likewise, it should be considered a priority to establish diagnostic reference levels for the different magnitudes that are defined in function of the modality and techniques used; this information is useful for the staff involved in procedures that use ionizing radiation.


Asunto(s)
Dosis de Radiación , Intensificación de Imagen Radiográfica , Sistema de Registros , Instituciones de Salud , Humanos , Cooperación Internacional
6.
Radiologia ; 55 Suppl 2: 17-24, 2013 Dec.
Artículo en Español | MEDLINE | ID: mdl-24211195

RESUMEN

This article discusses the diagnostic reference levels for radiation exposure proposed by the International Commission on Radiological Protection (ICRP) to facilitate the application of the optimization criteria in diagnostic imaging and interventional procedures. These levels are normally established as the third quartile of the dose distributions to patients in an ample sample of centers and are supposed to be representative of good practice regarding patient exposure. In determining these levels, it is important to evaluate image quality as well to ensure that it is sufficient for diagnostic purposes. When the values for the dose received by patients are systematically higher or much lower than the reference levels, an investigation should determine whether corrective measures need to be applied. The European and Spanish regulations require the use of these reference values in quality assurance programs. For interventional procedures, the dose area product (or kerma area product) values are usually used as reference values together with the time under fluoroscopy and the total number of images acquired. The most modern imaging devices allow the value of the accumulated dose at the entrance to the patient to be calculated to optimize the distribution of the dose on the skin. The ICRP recommends that the complexity of interventional procedures be taken into account when establishing reference levels. In the future, diagnostic imaging departments will have automatic systems to manage patient dosimetric data; these systems will enable continuous dosage auditing and alerts about individual procedures that might involve doses several times above the reference values. This article also discusses aspects that need to be clarified to take better advantage of the reference levels in interventional procedures.


Asunto(s)
Dosis de Radiación , Radiografía Intervencional/normas , Humanos , Radiografía Intervencional/métodos , Valores de Referencia
7.
Radiat Prot Dosimetry ; 199(15-16): 1824-1828, 2023 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-37819323

RESUMEN

Currently, the most used methods of plastic scintillator (PS) manufacturing are cell casting and bulk polymerisation, extrusion, injection molding, whereas digital light processing (DLP) 3D printing technique has been recently introduced. For our research, we measured blue-emitting EJ-200, EJ-208, green-emitting EJ-260, EJ-262 cell cast and two types of blue-emitting DLP-printed PSs. The light output of the samples, with the same dimension of 10 mm × 10 mm × 10 mm, was compared. The light output of the samples, relative to the reference EJ-200 cell-cast scintillator, equals about 40-49 and 70-73% for two types of 3D-printed, and two green-emitting cell-casted PSs, respectively. Performance of the investigated scintillators is sufficient to use them in a plastic scintillation dosemeter operating in high fluence gamma radiation fields.


Asunto(s)
Radiometría , Conteo por Cintilación , Conteo por Cintilación/métodos , Impresión Tridimensional
8.
J Crohns Colitis ; 13(11): 1380-1386, 2019 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-30976785

RESUMEN

BACKGROUND AND AIMS: To evaluate the clinical outcomes in patients with IBD after switching from Remicade® to CT-P13 in comparison with patients who maintain Remicade®. METHODS: Patients under Remicade® who were in clinical remission with standard dosage at study entry were included. The 'switch cohort' [SC] comprised patients who made the switch from Remicade® to CT-P13, and the 'non-switch' cohort [NC] patients remained under Remicade®. RESULTS: A total of 476 patients were included: 199 [42%] in the SC and 277 [58%] in the NC. The median follow-up was 18 months in the SC and 23 months in the NC [p < 0.01]. Twenty-four out of 277 patients relapsed in the NC; the incidence of relapse was 5% per patient-year. The cumulative incidence of relapse was 2% at 6 months and 10% at 24 months in this group. Thirty-eight out of 199 patients relapsed in the SC; the incidence rate of relapse was 14% per patient-year. The cumulative incidence of relapse was 5% at 6 months and 28% at 24 months. In the multivariate analysis, the switch to CT-P13 was associated with a higher risk of relapse (HR = 3.5, 95% confidence interval [CI] = 2-6). Thirteen percent of patients had adverse events in the NC, compared with 6% in the SC [p < 0.05]. CONCLUSIONS: Switching from Remicade® to CT-P13 might be associated with a higher risk of clinical relapse, although this fact was not supported in our study by an increase in objective markers of inflammation. The nocebo effect might have influenced this result. Switching from Remicade® to CT-P13 was safe.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Fármacos Gastrointestinales/uso terapéutico , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Infliximab/uso terapéutico , Adulto , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos
11.
Biochimie ; 67(3-4): 417-22, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3899194

RESUMEN

Aiming to decrease the acute side effects and genotoxic hazards of PUVA, pyrido (3,4-C) psoralen (PP) and 7-methyl pyrido (3,4-C) psoralen (MPP) were synthesized and studied. Their UVA maximum absorption lies at 325 and 330 nm, respectively. Their photostability is comparable to that of 8-MOP. They complex to DNA in the dark, and, in the presence of UVA, produce only monoadditions to DNA, as shown by fluorescence and DNA denaturation-renaturation studies. In diploid eukaryotic yeast they are more effective than 8-MOP for the induction of lethal effects and mitochondrial damage. Their mutagenic activity per unit dose of UVA is in the same range as that of 8-MOP. However, per viable cell they are clearly less mutagenic than 8-MOP. This difference is also observed for recombinogenic activity. No oxygen effect is observed. In mammalian cells the following ranges of effectiveness are found: inhibition of DNA synthesis in human fibroblasts: MPP greater than PP greater than 8-MOP; mutagenic activity in V79 Chinese hamster cells: MPP greater than PP greater than 8-MOP; cell transforming ability in C3H embryonic mouse cells: MPP greater than 8-MOP greater than PP as a function of UVA dose, and: 8-MOP greater than MPP greater than PP as a function of survival; induction of sister chromatic exchanges (SCE) per unit dose: MPP greater than PP greater than 8-MOP in the linear part of the induction curve, and : 8-MOP greater than PP greater than MPP at the maximum level of SCE obtained.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Furocumarinas/uso terapéutico , Terapia PUVA , 5-Metoxipsoraleno , Animales , Carcinoma Basocelular/inducido químicamente , Carcinoma de Células Escamosas/inducido químicamente , Eritema/inducido químicamente , Furocumarinas/efectos adversos , Humanos , Metoxaleno/efectos adversos , Metoxaleno/uso terapéutico , Pruebas de Mutagenicidad , Mutación , Terapia PUVA/efectos adversos , Terapia PUVA/métodos , Dolor , Fotoquímica , Trastornos de la Pigmentación/inducido químicamente , Neoplasias Cutáneas/inducido químicamente
12.
J Med Chem ; 43(9): 1684-91, 2000 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-10794685

RESUMEN

A series of indolylmethylamine derivatives were assayed toward MAO-A and MAO-B inhibition. The K(i) values of these compounds are in the range from 0.8 to >10(6) nM for MAO-A or from 0.75 to 476000 nM for MAO-B. The most selective MAO-A or MAO-B inhibitors elicit a ratio of K(i) in the order of 1500 or 1000, respectively. Comparison of MAO-A and MAO-B CoMFA models showed that both the steric and electrostatic properties at the 5 position of the indole ring are determinant for MAO selectivity. Computational simulations of the complex between this part of the ligand and Phe-208 of MAO-A or Ile-199 of MAO-B, experimentally identified as responsible for substrate selectivity, allowed us to further characterize the nature of these enzyme-inhibitor interactions.


Asunto(s)
Aminas/síntesis química , Indoles/síntesis química , Inhibidores de la Monoaminooxidasa/síntesis química , Monoaminooxidasa/química , Animales , Simulación por Computador , Técnicas In Vitro , Indoles/farmacología , Isoenzimas/química , Isoenzimas/genética , Isoleucina/química , Cinética , Ligandos , Masculino , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/enzimología , Modelos Moleculares , Monoaminooxidasa/genética , Inhibidores de la Monoaminooxidasa/química , Inhibidores de la Monoaminooxidasa/farmacología , Fenilalanina/química , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad
13.
Neuroscience ; 101(3): 619-27, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11113311

RESUMEN

In vivo microdialysis was used to characterize basal dopamine dynamics and cocaine-evoked dopamine levels in the medial prefrontal cortex of male Sprague-Dawley rats that had previously received once daily injections of cocaine (days 1-5; 20mg/kg, i.p.) in combination with the selective kappa-opioid receptor agonist U-69593 (days 3-5; 0.32mg/kg, s.c.) or its vehicle. The influence of these treatments on [3H]dopamine uptake in medial prefrontal cortex synaptosomes was also determined. Three days following the cessation of drug treatment, animals with prior history of cocaine administration exhibited enhanced psychomotor stimulation in response to a subsequent cocaine challenge. This effect was not apparent in animals that had previously received the cocaine treatment regimen in combination with the kappa-opioid receptor agonist U-69593. Cocaine challenge increased prefrontal dopamine levels in all pretreatment groups, but cocaine-pre-exposed animals had lower cocaine-evoked dopamine levels and higher basal in vivo extraction fraction, indicative of an increase in basal dopamine uptake relative to controls. Pretreatment with U-69593 prevented these effects of cocaine. Measurement of [3H]dopamine uptake in synaptosomes revealed a significant increase in uptake three days after the cessation of cocaine treatment. No increase in uptake was observed in animals that had received the cocaine treatment regimen in combination with U-69593. These results demonstrate that the early phase of abstinence from cocaine is associated with marked alterations in medial prefrontal cortex dopamine neurotransmission and that these neuroadaptations are prevented by the activation of kappa-opioid receptors. Furthermore, they raise the possibility that mesocortical dopamine neurons may be an important neural substrate upon which kappa-opioid agonists act to prevent the development of cocaine-induced behavioral sensitization.


Asunto(s)
Bencenoacetamidas , Trastornos Relacionados con Cocaína/metabolismo , Cocaína/farmacología , Dopamina/metabolismo , Vías Nerviosas/efectos de los fármacos , Neuronas/efectos de los fármacos , Corteza Prefrontal/efectos de los fármacos , Receptores Opioides kappa/agonistas , Síndrome de Abstinencia a Sustancias/metabolismo , Transmisión Sináptica/efectos de los fármacos , Área Tegmental Ventral/efectos de los fármacos , Analgésicos/farmacología , Animales , Trastornos Relacionados con Cocaína/patología , Trastornos Relacionados con Cocaína/fisiopatología , Interacciones Farmacológicas/fisiología , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/metabolismo , Masculino , Microdiálisis , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Vías Nerviosas/citología , Vías Nerviosas/metabolismo , Neuronas/citología , Neuronas/metabolismo , Corteza Prefrontal/citología , Corteza Prefrontal/metabolismo , Pirrolidinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Opioides kappa/metabolismo , Síndrome de Abstinencia a Sustancias/patología , Síndrome de Abstinencia a Sustancias/fisiopatología , Transmisión Sináptica/fisiología , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Área Tegmental Ventral/citología , Área Tegmental Ventral/metabolismo
14.
Biochem Pharmacol ; 55(1): 37-43, 1998 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-9413928

RESUMEN

The relationship between monoamine oxidase (EC 1.4.3.4; MAO) and peroxidase (EC 1.11.1.7; POD) in the metabolism of tyramine was investigated using the crude mitochondrial fraction of rat intestine. When tyramine was incubated with mitochondria, the formation of the peroxidase-catalysed oxidation product, 2,2'-dihydroxy-5,5'-bis(ethylamino)diphenyl (dityramine), identified by mass spectrometric analysis, was monitored spectrophotometrically. After an initial lag time, the formation rate of dityramine was linear up to 2 hr, amounting to 17 nmol x hr(-1) x mg protein(-1). A similar value was found for the oxidative deamination of tyramine catalysed by intestinal MAO. Either 10(-3) M clorgyline or 10(-3) M NaCN suppressed this reaction by completely inhibiting MAO or POD, respectively. In the former case, however, addition of H2O2 to the incubation mixture promptly started the reaction. Selective inhibition of MAO-A and MAO-B was achieved with 3 x 10(-7) M clorgyline and 3 x 10(-7) M deprenyl, respectively, and the formation rate of dityramine decreased in a corresponding manner. Preincubation with histamine or spermidine reduced the lag time without affecting the steady-state reaction rate. Higher levels of dityramine were also detected in vivo in rat intestine after oral administration of tyramine. These results indicate that the peroxidase-dependent metabolism of tyramine in the gut may be driven by H2O2 produced by MAO activities and that MAO-A is mainly responsible for this process, as well as for the oxidative deamination of tyramine.


Asunto(s)
Intestinos/enzimología , Mitocondrias/enzimología , Monoaminooxidasa/metabolismo , Peroxidasa/metabolismo , Tiramina/metabolismo , Animales , Dimerización , Cinética , Masculino , Oxidación-Reducción , Ratas , Ratas Wistar
15.
J Neural Transm Suppl ; 52: 343-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9564637

RESUMEN

Three different indolalkylamine derivatives (FA 102, FA 69, FA 70) having in common an -OH group at 5 position of the indole ring and differing in the presence of a methyl group at the N or the acetylenic group of the side chain, have been synthesized and assayed as monoamine oxidase-A (MAO-A) [E.C.1.4.3.4] inhibitors. They were effective inhibitors with, in some cases, similar potencies to clorgyline. "In vitro" experiments were performed on rat brain synaptosomes to investigate whether these MAO-A inhibitors had any effect on noradrenaline (NA), dopamine (DA) and 5-hydroxytryptamine (5-HT) transport systems in different rat brain regions. The effect of these drugs were compared with those of clorgyline and 1-deprenyl. FA 102, FA 69, FA 70 behaved as inhibitors of 3H-monoamine uptake with similar rank of order of potency for amine uptake inhibition: 5-HT > DA > NA. The IC50 values for FA 102, FA 69, FA 70, respectively, were: 17 microM, 60 microM, 18 microM for 5HT uptake in cortex and 37 microM, 55 microM and 20 microM in hippocampus; 70 microM, 385 microM for NA uptake in cortex and 315 microM, 255 microM and 600 microM in hypothalamus; 270 microM, 160 microM, 40 microM for DA uptake in striatum. 1-Deprenyl was a very poor inhibitor of monoamine uptake, whereas clorgyline behaved similarly to these indolalkylamine derivatives. Comparing these results with the IC50 values of citalopram, nisoxetine and GBR12909, specific and selective inhibitors of 5-HT, NA and DA transport systems respectively, indicated that these indolalkylamine derivatives interact more strongly with the 5HT uptake system.


Asunto(s)
Monoaminas Biogénicas/metabolismo , Encéfalo/metabolismo , Indoles/farmacología , Inhibidores de la Monoaminooxidasa/farmacología , Sinaptosomas/metabolismo , Animales , Encéfalo/efectos de los fármacos , Corteza Cerebral/metabolismo , Clorgilina/farmacología , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Hipocampo/metabolismo , Indoles/química , Cinética , Masculino , Estructura Molecular , Inhibidores de la Monoaminooxidasa/síntesis química , Norepinefrina/metabolismo , Especificidad de Órganos , Ratas , Ratas Sprague-Dawley , Serotonina/metabolismo , Relación Estructura-Actividad
16.
Mutat Res ; 136(1): 49-54, 1984 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-6371513

RESUMEN

The dark mutagenicity of 4,5',8-trimethylpsoralen (4,5',8-TMP), 5-methoxypsoralen (5-MOP), 8-methoxypsoralen (8-MOP), 3-carbethoxypsoralen (3-CPs) and two new pyridopsoralens (PyPs and MePyPs) was tested using the Ames Salmonella plating assay in the absence of metabolic activation. 4,5',8-TMP, 8-MOP and the two pyridopsoralens were found to be weak frameshift mutagens in strain TA1537 whereas 5-MOP and 3-CPs did not demonstrate any significant mutagenic activity. These findings support the notion that the genetic risks of these psoralens in the dark may be considered to be negligible.


Asunto(s)
Furocumarinas/farmacología , Mutación/efectos de los fármacos , Oscuridad , Salmonella typhimurium/efectos de los fármacos , Relación Estructura-Actividad
17.
Am Surg ; 64(9): 889-93, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9731821

RESUMEN

Retrosternal goiter is defined as any goiter in which at least 50 per cent of the thyroid resides below the level of the thoracic inlet. The incidence of retrosternal goiter varies from 3 to 20 per cent with respect to thyroidectomy patients. A retrospective chart review from June 1991 to December 1997 found 232 thyroidectomies performed at our institution. Sixteen patients were found to have retrosternal goiters (6.9%). The mean age was 57.8 years (range, 34-92). All were of benign pathology. Symptoms included shortness of breath (68.8%), hoarseness (37.5%), dysphagia (31.3%), and superior vena cava obstruction (6.25%). Thirteen patients were female (81.3%). Fifteen patients had surgical intervention (93.8%). Total thyroidectomy was performed in nine cases (60%), whereas lobectomy was performed in six cases (40%). All treated patients had complete resolution of symptoms. A cervical incision alone was used in 13 cases (86.7%). Complications consisted of one postoperative pleural effusion and in one case a traumatic C5 nerve root compression occurred. There were no instances of long-term vocal cord paralysis or hypoparathyroidism. There was no perioperative mortality. In the majority of patients with retrosternal goiter, surgery can be done expeditiously through a cervical incision with minimal morbidity and mortality.


Asunto(s)
Bocio Subesternal/cirugía , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Trastornos de Deglución/fisiopatología , Disnea/fisiopatología , Femenino , Bocio Subesternal/patología , Bocio Subesternal/fisiopatología , Ronquera/fisiopatología , Humanos , Hipoparatiroidismo/etiología , Masculino , Persona de Mediana Edad , Síndromes de Compresión Nerviosa/etiología , Derrame Pleural/etiología , Estudios Retrospectivos , Factores Sexuales , Raíces Nerviosas Espinales/lesiones , Síndrome de la Vena Cava Superior/fisiopatología , Tasa de Supervivencia , Tiroidectomía/efectos adversos , Tiroidectomía/métodos , Parálisis de los Pliegues Vocales/etiología
18.
Arq Gastroenterol ; 19(1): 12-6, 1982.
Artículo en Inglés | MEDLINE | ID: mdl-6295347

RESUMEN

We review eight cases of early gastric cancer which occurred in five female and three male patients. In seven patients the main complaint was epigastric pain and in one melena. In seven of the eight cases, endoscopic diagnosis was established on the first examination and confirmed by biopsy. Types of early gastric cancer observed were: type I, one case; IIa, one case; IIc three cases: III, two cases and type III + IIc, one case. In five cases the neoplasia was located in the antrum, two in the pre-pyloric region, two along the greater curvature and one in the anterior wall. Three cases were located in the body of the stomach, two in the lower third of the lesser curvature and one in the upper third of the greater curvature. From the histopathologic standpoint four cases were differentiated adenocarcinomas, three undifferentiated adenocarcinomas and one case mucus carcinoma. In no case did we encounter regional lymph node metastases. Postoperative survival rates at the present time varies between one and five years.


Asunto(s)
Adenocarcinoma Mucinoso/diagnóstico , Adenocarcinoma/diagnóstico , Neoplasias Gástricas/diagnóstico , Adenocarcinoma/patología , Adenocarcinoma Mucinoso/patología , Adulto , Anciano , Femenino , Gastroscopía , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/patología
19.
Rev Neurol ; 52(10): 597-602, 2011 May 16.
Artículo en Español | MEDLINE | ID: mdl-21488007

RESUMEN

INTRODUCTION: Rett syndrome (RS) is a neurodevelopmental disorder that affects girls almost exclusively. The identification of mutations in the MECP2 and CDKL5 genes offers genetic confirmation of the clinical diagnosis. The FOXG1 gene appears to be a novel cause of the congenital variant of RS. CASE REPORT: We describe the first Spanish patient with the atypical (congenital) variant of RS with mutation of the FOXG1 gene and the case is compared with 12 patients previously reported in the literature; clinical criteria that suggest alterations in FOXG1 are proposed. The patient was referred at the age of 6 months due to overall retardation, axial hypotonia, microcephaly and a peculiar phenotype. Magnetic resonance imaging of the brain revealed hypoplasia of the corpus callosum, frontal atrophy and ventriculomegaly. The appearance of hand-to-mouth stereotypic movements at 12 months pointed the clinical diagnosis towards an atypical variant of RS, the congenital form; there was progressive improvement of visual contact and interest in her surroundings. Frequent respiratory infections and obstructive sleep apnoea syndrome. At the age of 5 years there was partial control over the axial tone, grasping with the hands, good contact and babbling, without epilepsy or behavioural disorders. The MECP2 and subtelomeric deletion study did not reveal any alterations; two polymorphisms were identified in the CDKL5 gene and a pathogenic mutation was found in FOXG1 (c.624C>G p.Tyr203X). CONCLUSIONS: It has been shown that 92% of patients with mutations in the FOXG1 gene present the congenital form of RS with severe generalised hypotonia, early acquired microcephaly (-3 to -6 standard deviations) and peculiar phenotype. When faced with a diagnosis of RS with no alterations in the MECP2 and CDKL5 genes, especially in the case of the congenital variant, the FOXG1 gene must be investigated. The molecular diagnosis confirms the clinical diagnosis and provides the family with genetic counselling.


Asunto(s)
Factores de Transcripción Forkhead/genética , Mutación , Proteínas del Tejido Nervioso/genética , Síndrome de Rett/genética , Encéfalo/patología , Encéfalo/fisiopatología , Preescolar , Femenino , Humanos , Microcefalia/genética , Fenotipo , Síndrome de Rett/patología , Síndrome de Rett/fisiopatología , España
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA